Specialists in biomolecules
Bioiberica has begun the manufacture and marketing of an innovative range of chondroprotector products for dogs and cats with osteoarthritis, Condrovet® Force HA. This is a new generation of products that protect against joint wear among small pets, with a combination of ingredients exclusive to the market: chondroitin sulfate (100% pure), glucosamine (99% pure), hyaluronic acid and native type II collagen.
“After 20 years in the companion animal sector, focusing on joint health, we are proposing to develop our products”, said Alfonso Velasco, director of Bioiberica Companion Animals.
It is estimated that there are about 20% of dogs over 1 year of age that have osteoarthritis. Condrovet® Force HA is recommended specifically for dogs and cats with osteoarthritis and degenerative joint cartilage processes due to old age, a high level of exercise or excess weight. It is also suitable after joint surgery to ensure better animal recovery. The products enjoy the scientific endorsement of more than 150 publications and have been shown to reduce pain and improve joint mobility, in addition to slowing down the progression of disease.
Specifically, chondroitin sulphate (CSBioactive®) stimulates the synthesis of proteoglycans and other components of the cartilage matrix; glucosamine HCI inhibits proteolytic enzymes and other cartilage-damaging molecules; hyaluronic acid (Mobilee®) helps reduce inflammation of the synovial membrane, improving mobility; and natural type II collagen (b-2Cool®) makes it possible to reduce the destruction of endogenous collagen in the joint.
Condrovet® Force HA Perros for dogs comes in packs of 120, 240 and 500 tablets, and Condrovet® Force HA Gatos for cats in packs of 45 tasty capsules.
Bioiberica is a firm specialising in the research, manufacture and marketing of the principal chondroprotector molecules for osteoarthritis: chondroitin sulfate, glucosamine and hyaluronic acid, for human and animal health alike.